ROYALTY TRANSFER AGREEMENTRoyalty Transfer Agreement • September 11th, 2020 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledSeptember 11th, 2020 Company Industry JurisdictionThis Royalty Transfer Agreement (the “Agreement”) is made and entered into as of March 31, 2016 (the “Effective Date”), by and between Oncorus, Inc., a Delaware corporation (the “Company”), MPM Oncology Charitable Foundation, Inc., a Massachusetts charitable foundation (the “MPM Charitable Foundation”) and the UBS Optimus Foundation, a Swiss charitable foundation (“Optimus,” and together with the MPM Charitable Foundation, the “Charitable Foundations”).
ROYALTY TRANSFER AGREEMENTRoyalty Transfer Agreement • October 31st, 2019 • Oncorus, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 31st, 2019 Company Industry JurisdictionThis Royalty Transfer Agreement (the “Agreement”) is made and entered into as of March 31, 2016 (the “Effective Date”), by and between Oncorus, Inc., a Delaware corporation (the “Company”), MPM Oncology Charitable Foundation, Inc., a Massachusetts charitable foundation (the “MPM Charitable Foundation”) and the UBS Optimus Foundation, a Swiss charitable foundation (“Optimus,” and together with the MPM Charitable Foundation, the “Charitable Foundations”).